510(k) K260696
K260696 is an FDA 510(k) premarket notification submitted by Liofilchem S.R.L. for the device "MTS Gepotidacin 0.016-256 µg/mL". The FDA issued a decision of Substantially Equivalent on Apr 17, 2026. The device falls under product code JWY (Manual Antimicrobial Susceptibility Test Systems), a Class II device regulated under 21 CFR 866.1640. Liofilchem S.R.L. has 37 other 510(k) clearances on record.
Clearance details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- Apr 17, 2026
- Date Received
- Mar 3, 2026
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device classification
- Device Name
- Manual Antimicrobial Susceptibility Test Systems
- Device Class
- Class II
- Regulation Number
- 866.1640
- Review Panel
- MI
- Submission Type
- 510(k)
Need the full FDA record for Liofilchem S.R.L.? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.